Suppr超能文献

血管活性肠肽的结合及其通过大鼠肝细胞膜上两类受体对腺苷酸环化酶的刺激作用。12种促胰液素类似物和2种促胰液素片段的作用。

Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.

作者信息

Waelbroeck M, Robberecht P, De Neef P, Chatelain P, Christophe J

出版信息

Biochim Biophys Acta. 1981 Nov 18;678(1):83-90. doi: 10.1016/0304-4165(81)90050-7.

Abstract
  1. Vasoactive intestinal peptide (VIP) receptors were identified in crude rat hepatic membranes by 125I-labelled VIP binding and by the ability of VIP to stimulate adenylate cyclase activity. The specificity of these receptors was evaluated by the capacity of secretin, synthetic secretin analogues, and secretin fragments to inhibit 125I-labelled VIP binding and to stimulate adenylate cyclase. 2. The results were compatible with the existence of two classes of VIP binding sites that could be distinguished according to their affinity for VIP and their specificity. High-affinity sites were more specific for VIP as secretin was 175 times less potent than VIP for recognition of these sites while being only 33 times less potent than VIP for recognition of low-affinity sites. 3. Secretin analogues, monosubstituted in position 2, 3, 4 or 6 were less potent than secretin for adenylate cyclase stimulation as well as for the recognition of the two classes of receptors. [Val5]secretin was more potent than secretin and appeared definitely more VIP-like than secretin; [Ala4, Val5] and [D-Ala4,Val5]secretin were equipotent to secretin. 4. The fragment secretin (7-27) was unable to recognize VIP receptors and to stimulate adenylate cyclase. The substituted fragment [Gln9,Asn15]secretin (5-27) recognized these receptors with weak potency but could not activate the enzyme.
摘要
  1. 通过¹²⁵I标记的血管活性肠肽(VIP)结合以及VIP刺激腺苷酸环化酶活性的能力,在大鼠肝粗膜中鉴定出VIP受体。通过促胰液素、合成促胰液素类似物和促胰液素片段抑制¹²⁵I标记的VIP结合以及刺激腺苷酸环化酶的能力,评估了这些受体的特异性。2. 结果与两类VIP结合位点的存在相符,这两类位点可根据它们对VIP的亲和力及其特异性加以区分。高亲和力位点对VIP更具特异性,因为促胰液素识别这些位点的效力比VIP低175倍,而识别低亲和力位点的效力仅比VIP低33倍。3. 在第2、3、4或6位单取代的促胰液素类似物,在刺激腺苷酸环化酶以及识别两类受体方面,效力均低于促胰液素。[Val⁵]促胰液素比促胰液素效力更强,而且显然比促胰液素更像VIP;[Ala⁴,Val⁵]和[D-Ala⁴,Val⁵]促胰液素与促胰液素效力相当。4. 促胰液素片段(7 - 27)无法识别VIP受体,也不能刺激腺苷酸环化酶。取代片段[Gln⁹,Asn¹⁵]促胰液素(5 - 27)识别这些受体的效力较弱,但不能激活该酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验